发明名称 |
Combined treatment with oxaliplatin and an epidermal growth factor receptor kinase inhibitor |
摘要 |
The present invention provides a method for treating tumors or tumor metastases in a patient, comprising administering to the patient simultaneously or sequentially a therapeutically effective amount of an EGFR kinase inhibitor and oxaliplatin combination, with or without additional agents or treatments, such as other anti-cancer drugs or radiation therapy. The invention also encompasses a pharmaceutical composition that is comprised of an EGFR kinase inhibitor and oxaliplatin combination in combination with a pharmaceutically acceptable carrier. A preferred example of an EGFR kinase inhibitor that can be used in practicing this invention is the compound erlotinib HCl (also known as Tarceva(TM)).
|
申请公布号 |
US2005272738(A1) |
申请公布日期 |
2005.12.08 |
申请号 |
US20050145091 |
申请日期 |
2005.06.03 |
申请人 |
CHEN JIANPING;HIGGINS BRIAN;KOLINSKY KENNETH |
发明人 |
CHEN JIANPING;HIGGINS BRIAN;KOLINSKY KENNETH |
分类号 |
A61K31/28;A61K31/4706;A61K31/498;A61K31/517;A61K31/519;A61K31/5377;A61K33/24;A61K38/50;(IPC1-7):A61K31/498 |
主分类号 |
A61K31/28 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|